We read with interest the article by Gencher et al., investigating specialty-related differences in the implementation of guideline-directed medical therapy (GDMT) for patients hospitalized with heart failure (HF) using data from the VOCAL-AHF registry [1]. Their structured approach, stratifying patients not only by ejection fraction (EF), but also by clinical eligibility and the presence of indication and absence of contraindications, offers valuable clarity in a field where raw treatment rates are frequently misinterpreted.
